Demystifying Biosimilar and Interchangeable Insulin

Speciality: Endocrinology


Speaker:

Dr. Jayashree Gopal | MBBS, Diploma - Endocrinology. Consultant - Endocrinology. 21 Years Of Experience Endocrinologist

Description:

A warm welcome to all the medical practitioners in this interesting session on untangling the benefits, needs, costs, and access to biosimilar and interchangeable insulin.

Insulin is a hormone secreted from the pancreas that helps blood sugar to enter the body's cells so it can be used for energy. Insulin also signals the liver to store blood sugar for later use. It is one of the important components that help in controlling diabetes in patients.

Biosimilar insulins are manufactured in living organisms (e.g., yeast and bacteria) to produce large quantities of the product, which limits the ability to manufacture exact replicas of original biological medications. The manufacture and use of biosimilar insulin will be much more cost-effective and can be used in lower or middle-income countries. 

Insulin glargine is a product of Biocon, a long-acting, synthetic version of human insulin that works by replacing the normally produced insulin and by helping sugar to move out from the blood into other body tissues where it is used in the form of energy. 

Therefore, listen to the webinar, grab the knowledge that is shared, and follow HiDoc for more such interesting webinar sessions.
 


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.

2.

Study identifies new approach to protect the brain during radiation therapy

3.

While most cancer screenings won't prolong lives, there are still good reasons to continue screening.

4.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

5.

Radiation therapy for patients with breast cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot